Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy
作者： Kenji Ishitsuka , Shiro Jimi , Victor S. Goldmacher , Olga Ab , Kazuo Tamura
DOI: 10.1111/J.1365-2141.2008.07000.X
关键词: Modality (human–computer interaction) 、 Targeted therapy 、 Maytansinoid 、 Immunology 、 Malignancy 、 Immunoconjugate 、 Medicine 、 Natural killer T cell 、 HuN901-DM1 、 Cancer research 、 Hematology
摘要:
sci-hub.se 参考文章(8)
Pierfrancesco Tassone, Antonella Gozzini, Victor Goldmacher, Masood A. Shammas, Kathleen R. Whiteman, Daniel R. Carrasco, Cheng Li, Charles K. Allam, Salvatore Venuta, Kenneth C. Anderson, Nikhil C. Munshi, In Vitro and in Vivo Activity of the Maytansinoid Immunoconjugate huN901-N2′-Deacetyl-N2′-(3-Mercapto-1-Oxopropyl)-Maytansine against CD56+ Multiple Myeloma Cells Cancer Research. ,vol. 64, pp. 4629- 4636 ,(2004) , 10.1158/0008-5472.CAN-04-0142
Lintao Wang, Godfrey Amphlett, Walter A. Blättler, John M. Lambert, Wei Zhang, Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry Protein Science. ,vol. 14, pp. 2436- 2446 ,(2005) , 10.1110/PS.051478705
Asher Alban Chanan-Khan, Sundar Jagannath, Robert L. Schlossman, Robert J. Fram, Richard M. Falzone, Mary F. Ruberti, Samantha K. Welch, Dawn DePaolo, Kenneth C. Anderson, Nikhil C. Munshi, Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma. Blood. ,vol. 108, pp. 3574- 3574 ,(2006) , 10.1182/BLOOD.V108.11.3574.3574
Jiang-Hong Gong, G Maki, H.-G Klingemann, Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells Leukemia. ,vol. 8, pp. 652- 658 ,(1994)
J. McCann, F. V. Fossella, M. A. Villalona-Calero, A. W. Tolcher, P. Fidias, R. Raju, S. Zildjian, R. Guild, R. Fram, Phase II trial of huN901-DM1 in patients with relapsed small cell lung cancer (SCLC) and CD56-positive small cell carcinoma Journal of Clinical Oncology. ,vol. 25, pp. 18084- 18084 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.18084
Kazuo Oshimi, Keisei Kawa, Shigeo Nakamura, Ritsuro Suzuki, Junji Suzumiya, Motoko Yamaguchi, Junichi Kameoka, Shinichi Tagawa, Nobutaka Imamura, Koichi Ohshima, Shizuo Kojya, Keiji Iwatsuki, Yoshiki Tokura, Eriko Sato, Hiroki Sugimori, NK-cell neoplasms in Japan Hematology. ,vol. 10, pp. 237- 245 ,(2005) , 10.1080/10245330400026162
S. Morris Kupchan, Y. Komoda, W. A. Court, G. J. Thomas, R. M. Smith, A. Karim, C. J. Gilmore, R. C. Haltiwanger, R. F. Bryan, Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. Journal of the American Chemical Society. ,vol. 94, pp. 1354- 1356 ,(1972) , 10.1021/JA00759A054
Jeeyun Lee, Cheolwon Suh, Yeon Hee Park, Young H. Ko, Soo Mee Bang, Jae Hoon Lee, Dae Ho Lee, Jooryung Huh, Sung Yong Oh, Hyuk-Chan Kwon, Hyo Jin Kim, Soon Il Lee, Jung Han Kim, Jinny Park, Seok Joong Oh, Kihyun Kim, Chulwon Jung, Keunchil Park, Won Seog Kim, Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study Journal of Clinical Oncology. ,vol. 24, pp. 612- 618 ,(2006) , 10.1200/JCO.2005.04.1384